🔎 Trials Near Me

Home › Peripheral T-Cell Lymphoma

Peripheral T-Cell Lymphoma clinical trials recruiting in the U.S.

20 studies for Peripheral T-Cell Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT04083495

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

RecruitingEarly phase 1
Ages 1 to 31 · All sexes · Updated Aug 18, 2026 · NCT03719105

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07750886

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Recruiting
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT04045470

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06072131

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Jul 20, 2026 · NCT06176690

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06508463

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT04068597

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05313243

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Jun 4, 2026 · NCT06131801

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245

Amping up With PemJAK

RecruitingPhase 2
Ages 18 to 95 · All sexes · Updated Dec 16, 2025 · NCT07283822

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2025 · NCT03964480

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.